Lee Henneken

Appearances

OAT AVENIN TRIGGERS ACUTE SYMPTOMS AND IMMUNE ACTIVATION IN SOME PEOPLE WITH CELIAC DISEASE BUT ADVERSE IMMUNE AND CLINICAL EFFECTS ARE ABSENT WITH EXTENDED INGESTION
Date
May 6, 2023
BACKGROUND: Contamination-free oats are considered safe for most patients with celiac disease (CeD)…
Presenter
Melinda Hardy
Speakers
Amy Russell
Lee Henneken
Greg Tanner
Frank Bekes
Sam Olechnowicz
Hugh Reid
Jamie Rossjohn
Jason Tye-Din
A BISPECIFIC ANTIBODY TARGETING HLA-DQ2.5-GLUTEN PEPTIDES POTENTLY BLOCKS GLUTEN-SPECIFIC T CELLS INDUCED BY GLUTEN INGESTION IN PATIENTS WITH CELIAC DISEASE
Date
May 6, 2023
BACKGROUND: Contamination-free oats are considered safe for most patients with celiac disease (CeD)…
Presenter
Melinda Hardy
Speakers
Lee Henneken
Amy Russell
Akihiko Mizoroki
Yui Ozono
Yuu Okura
Yosuke Murakami
Shinta Kobayashi
Jason Tye-Din
GLUTEN-SPECIFIC CD4+ T CELL DETECTION USING A WHOLE BLOOD INTERLEUKIN-2 RELEASE ASSAY IS SENSITIVE AND SPECIFIC FOR CELIAC DISEASE
Date
May 19, 2024
BACKGROUND: Celiac disease (CeD) is prevalent but frequently undiagnosed. Central to its pathogenesis are proinflammatory HLA-DQ-restricted gluten-specific CD4+ T cells in the intestine and circulation…
Presenter
Olivia Moscatelli
Speakers
Amy Russell
Lee Henneken
Linda Fothergill
Vanessa Bryant
Jason Tye-Din
A WHOLE BLOOD INTERLEUKIN-2 RELEASE ASSAY OFFERS HIGHER SENSITIVITY TO DETECT GLUTEN-SPECIFIC CD4+ T CELLS THAN INTERFERON-γ ELISPOT IN CELIAC DISEASE AND ACCURATELY REFLECTS GLUTEN PEPTIDE IMMUNOGENICITY
Date
May 20, 2024
INTRODUCTION: Celiac disease (CeD) is caused by proinflammatory gluten-specific CD4+ T cells that reside in the small intestine and circulation at low frequency…
Presenter
Olivia Moscatelli
Speakers
Amy Russell
Lee Henneken
Linda Fothergill
Vanessa Bryant
Jason Tye-Din